Terms: = Breast cancer AND MYD88, Q99836, MYD88D, 4615 AND Diagnosis
4 results:
1. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract] [Full Text] [Related]
2. cancer and cancer survival modulates brain and behavior in a time-of-day-dependent manner in mice.
Santos JC; Bever SR; Sullivan KA; Pyter LM
Sci Rep; 2019 Apr; 9(1):6497. PubMed ID: 31019214
[TBL] [Abstract] [Full Text] [Related]
3. Increased expression of myd88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract] [Full Text] [Related]
4. Significance of TLR4/myd88 expression in breast cancer.
Chen X; Zhao F; Zhang H; Zhu Y; Wu K; Tan G
Int J Clin Exp Pathol; 2015; 8(6):7034-9. PubMed ID: 26261595
[TBL] [Abstract] [Full Text] [Related]
